Top Buy
| Security | Buy | Sell | Buy (1W) ▼ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Eli Lilly Corp. | 68 | 0 | 2 | 0 | €867.80 | €883.50 | 1.809% |
| Puma Biotechnology Inc. | 2 | 0 | 2 | 0 | €2.22 | - | - |
| Neurocrine Bioscience | 45 | 0 | 2 | 0 | €115.00 | €149.74 | 30.205% |
| Krystal Biotech | 20 | 0 | 2 | 0 | €176.40 | €185.58 | 5.204% |
| MannKind Corp. | 9 | 0 | 1 | 0 | €5.66 | €6.44 | 13.756% |
| Novavax Inc. | 6 | 2 | 1 | 0 | €11.20 | €21.98 | 96.277% |
| Arca Biopharma | 1 | 17 | 1 | 0 | €2.22 | €7.50 | 237.838% |
| Merck & Co. Inc. | 33 | 1 | 1 | 0 | €107.20 | €125.91 | 17.451% |
| Codexis Inc. | 8 | 1 | 1 | 0 | €2.62 | €9.31 | 254.611% |
| EyePoint Pharmaceuticals Inc. | 21 | 1 | 1 | 0 | €7.93 | €27.91 | 251.904% |
| BioMarin Pharmaceutical Inc. | 23 | 0 | 1 | 0 | €82.52 | €102.48 | 24.183% |
| Zoetis Inc. A | 25 | 1 | 1 | 0 | €166.00 | €198.11 | 19.344% |
| Insmed Inc. | 47 | 0 | 1 | 0 | €68.50 | €77.59 | 13.271% |
| United Therapeutics | 27 | 1 | 1 | 0 | €329.00 | €341.51 | 3.802% |
| Pfizer Inc. | 32 | 4 | 1 | 0 | €26.24 | €41.49 | 58.156% |
| Immunic Inc. | 5 | 3 | 1 | 0 | €1.37 | €6.61 | 381.933% |
| MacroGenics Inc. | 14 | 0 | 1 | 0 | €3.18 | €12.31 | 286.950% |
| Regeneron Pharmaceuticals Inc. | 47 | 1 | 1 | 0 | €1,072.0 | €1,091.9 | 1.858% |
| Alnylam Pharmace. | 46 | 1 | 1 | 1 | €237.70 | €271.50 | 14.221% |
| PTC Therapeutics Inc. | 15 | 9 | 1 | 0 | €31.60 | €41.51 | 31.369% |
| Incyte Corp. | 13 | 2 | 0 | 0 | €59.42 | €77.67 | 30.716% |
| Iovance Biotherapeutics Inc. | 20 | 2 | 0 | 0 | €10.56 | €26.24 | 148.565% |
| Akero Therapeutics Inc | 17 | 0 | 0 | 0 | €24.02 | €38.19 | 59.007% |
| Heron Therapeutics Inc. | 11 | 1 | 0 | 0 | €1.78 | €4.63 | 160.022% |
| Personalis Inc | 10 | 1 | 0 | 0 | €5.24 | €6.58 | 25.723% |